“…Many randomized, controlled trials and case–control studies of palliative care interventions to date have shown reductions in patients’ symptoms and health care utilization and improvements in quality of life and family satisfaction across a wide spectrum of populations, including patients with advanced cancer, 37 neurologic disease, 48 or lung disease 42 and older adults with multiple coexisting conditions and frailty. 6,49 The patient population that benefits most from referral to specialist-level palliative care and the appropriate timing of such referral are still being defined by empirical research, yet consensus recommendations support referral at the time of diagnosis for patients with advanced cancer, neurologic disease, or organ damage; those with multiple coexisting conditions, frailty, or advanced cognitive impairment; those with a high symptom or iatrogenic-treatment burden (e.g., those who have received a bone marrow transplant for acute leukemia); and those who have onerous family or caregiver needs regardless of prognosis. 2,36 …”